The Digestive Enzymes Market is anticipated to climb from USD 864.094 million in 2025 to USD 1,245.720 million by 2030, with a 7.59% CAGR.
Digestive enzymes are the complex proteins involved in breaking down complex macromolecules into their constituents for easy absorption and utilization by the body. Digestive enzymes need specific pH and temperature to work optimally. It is essential to maintain a healthy balance of digestive enzymes to optimize healthy digestion. Several digestive enzymes are commercially available as supplements for the management of digestive disorders. They are effective at relieving common issues, including occasional gas, bloating, indigestion, heartburn, and general discomfort. The market in digestive enzymes is estimated to show significant growth during the given forecast period owing to the rising prevalence of gastrointestinal and abdominal disorders. The shift from healthy eating habits will also propel the growth of the digestive enzymes market. Rising awareness among people regarding preventive health management will also have a significant positive on the growth of the market. However, the availability of alternatives such as probiotics and prebiotics will hamper the growth of the market.
The major players profiled in the Digestive Enzymes market include Enzymedica, Deerland Enzymes, Inc., AST Enzymes, Onnit Labs, Inc., Metagenics, National Enzyme Company Inc., Garden of Life Inc., Amway Corporation, and Country Life, LLC.
Segmentation